Khalil Barrage is a Managing Director at Invus, based in New York.
He joined Invus in 2003 and established its Public Equity activity. Since its inception, Invus Public Equity has concentrated its investments in the emerging innovative biotech companies. Prior to joining Invus, he worked at The Olayan Group in New York and ran their US equity portfolio for 15 years. He holds a BA in Economics from the American University of Beirut.
He is a member of the board of several biotechs including Celtaxsys and Protagenic Therapeutics in the US and Sensorion in France. Shareholders also approved the renewal of the term of office of Board member GammaX Corporate Advisory, represented by Mr. Jacques Mallet, for an additional 3-year term.